ArticleChemMedChem2020

Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.

Merissa Baxter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.